We are live on ! Find out more
CTA

Chesley Taft & Associates Portfolio holdings

AUM $2.57B
1-Year Est. Return 22.93%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+22.93%
3 Year Est. Return
+80.85%
5 Year Est. Return
+97.37%
10 Year Est. Return
+353.09%
AUM
$933M
AUM Growth
-$70.2M
Cap. Flow
-$83.2M
Cap. Flow %
-8.91%
Top 10 Hldgs %
21.05%
Holding
287
New
19
Increased
103
Reduced
83
Closed
38

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$6.14M
2
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$3.32M
3
CVS icon
CVS Health
CVS
+$2.81M
4
MA icon
Mastercard
MA
+$2.67M
5
HSY icon
Hershey
HSY
+$2.53M

Sector Composition

Rank Sector Weight
1 Healthcare 19.36%
2 Industrials 15.61%
3 Technology 12.01%
4 Consumer Staples 10.55%
5 Energy 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBI
26
DELISTED
Chicago Bridge & Iron Nv
CBI
$10.3M 1.11%
118,355
-1,240
-1% -$101K
PFE icon
27
Pfizer
PFE
$142B
$10.1M 1.08%
330,494
+1,608
+0.5% +$47.9K
SYK icon
28
Stryker
SYK
$133B
$9.95M 1.07%
122,098
-890
-0.7% -$70.8K
JCI icon
29
Johnson Controls International
JCI
$87.2B
$9.89M 1.06%
199,647
-3,075
-2% -$156K
HAL icon
30
Halliburton
HAL
$26.4B
$9.75M 1.05%
165,600
+2,200
+1% +$117K
GILD icon
31
Gilead Sciences
GILD
$163B
$9.54M 1.02%
134,612
-1,650
-1% -$129K
SPY icon
32
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$9.46M 1.01%
50,557
+914
+2% +$168K
MCK icon
33
McKesson
MCK
$101B
$9.36M 1%
52,999
-682
-1% -$119K
LKQ icon
34
LKQ Corp
LKQ
$5.76B
$9.28M 0.99%
352,102
+18,610
+6% +$521K
AAPL icon
35
Apple
AAPL
$4.9T
$9.2M 0.99%
479,892
+46,340
+11% +$881K
CHD icon
36
Church & Dwight Co
CHD
$23.1B
$9.01M 0.97%
260,920
-2,600
-1% -$86.3K
CLR
37
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$8.81M 0.94%
141,780
+1,300
+0.9% +$74.1K
QCOM icon
38
Qualcomm
QCOM
$159B
$8.79M 0.94%
111,430
-1,668
-1% -$126K
INTC icon
39
Intel
INTC
$460B
$8.55M 0.92%
331,205
+1,286
+0.4% +$32.1K
VZ icon
40
Verizon
VZ
$193B
$8.44M 0.9%
177,375
+129,805
+273% +$6.14M
EBAY icon
41
eBay
EBAY
$50.4B
$8.37M 0.9%
360,166
-30,981
-8% -$720K
CTSH icon
42
Cognizant
CTSH
$24.3B
$8.12M 0.87%
160,369
-257
-0.2% -$12.8K
CVS icon
43
CVS Health
CVS
$134B
$8.11M 0.87%
108,288
+39,750
+58% +$2.81M
IBM icon
44
IBM
IBM
$209B
$7.91M 0.85%
42,999
-41,148
-49% -$7.24M
BAX icon
45
Baxter International
BAX
$13.8B
$7.85M 0.84%
196,298
+22,460
+13% +$840K
TMO icon
46
Thermo Fisher Scientific
TMO
$214B
$7.75M 0.83%
64,495
+3,620
+6% +$430K
BCR
47
DELISTED
CR Bard Inc.
BCR
$7.68M 0.82%
51,879
-700
-1% -$96.9K
WMT icon
48
Walmart Inc
WMT
$884B
$7.58M 0.81%
297,321
+1,983
+0.7% +$49.8K
SBUX icon
49
Starbucks
SBUX
$121B
$7.26M 0.78%
197,900
+2,040
+1% +$75.4K
WFC icon
50
Wells Fargo
WFC
$258B
$6.87M 0.74%
138,198
-483
-0.3% -$22.5K

Similar funds

Chesley Taft & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Chesley Taft & Associates held 287 positions worth $933M, down 7% from $1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Chesley Taft & Associates withdrew a net $83.2M in Q1 2014, closing 38 positions and reducing 83 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $14.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

Against the trend, Chesley Taft & Associates opened a new position in SALIX PHARMACEUTICALS LTD DEL worth $3.36M.

  • Chesley Taft & Associates's largest Q1 2014 buy was SALIX PHARMACEUTICALS LTD DEL: 32,425 shares worth $3.36M.
  • Chesley Taft & Associates added most to Verizon in Q1 2014, an estimated $6.14M increase.
  • Chesley Taft & Associates's biggest Q1 2014 reduction was Vodafone, cutting an estimated $12.5M.
  • Chesley Taft & Associates fully exited iShares MSCI EAFE ETF in Q1 2014, selling an estimated $14.6M.
  • Chesley Taft & Associates's ten largest holdings make up 21% of its $933M portfolio in Q1 2014.
  • Chesley Taft & Associates opened 19 new positions and closed 38 in Q1 2014.
  • Chesley Taft & Associates's portfolio value fell 7% quarter-over-quarter to $933M.

Based on Chesley Taft & Associates's 13F filing for Q1 2014, filed 11 Apr 2014.